Vadodara-based speciality chemicals manufacturer and world's 3rd largest HMDS producer, making organic chemicals (HMDS, CMIC, Bromobenzene, 2-Bromo) and inorganic bromides (Calcium, Zinc, Sodium Bromide) for pharma, agrochemical and oilfiel
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 32 | 37 | 37 | 37 | 37 | 37 | 37 | 37 |
| Reserves | 115 | 317 | 381 | 421 | 440 | 464 | 476 | 447 |
| Borrowings | 46 | 6 | 36 | 64 | 43 | 25 | 0 | 53 |
| Other Liabilities | 34 | 44 | 45 | 32 | 26 | 29 | 35 | 32 |
| Total Liabilities | 226 | 404 | 498 | 553 | 545 | 554 | 548 | 568 |
| AssetsFixed Assets | 49 | 67 | 82 | 141 | 146 | 149 | 144 | 195 |
| CWIP | 4 | 9 | 34 | 14 | 42 | 40 | 47 | 21 |
| Investments | 0 | 0 | 0 | 0 | 0 | 10 | 11 | 10 |
| Other Assets | 173 | 328 | 382 | 398 | 356 | 355 | 346 | 342 |
| Total Assets | 226 | 404 | 498 | 553 | 545 | 554 | 548 | 568 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 11 | 12 | 65 | 74 | 13 | 12 | 41 | 42 |
| Cash from Investing | -24 | -16 | -152 | -92 | -16 | -25 | -19 | -35 |
| Cash from Financing | 12 | 4 | 111 | 30 | 12 | -25 | -22 | -3 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -2 | -2 | 34 | 24 | -32 | -31 | 31 | 32 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (35.2×) and current (29.9×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At -24.6% growth and a 30× exit, ₹193 only delivers your return if you pay ₹17. The price is currently baking in 17% growth.
EPS grows -24.6%/yr for 5 years, then fades to 6% over 2, exits at 30×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | -24.6% | 4.86 |
| FY28 | -24.6% | 3.66 |
| FY29 | -24.6% | 2.76 |
| FY30 | -24.6% | 2.08 |
| FY31 | -24.6% | 1.57 |
| FY32 | -9.3% ·fade | 1.42 |
| FY33 | 6.0% ·fade | 1.51 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.